Authors: Oncology Central
The field of liquid biopsy in cancer has generated significant interest over the past decade and this interest continues to build, as it offers the potential to simply and accurately isolate and analyze key biomarkers for personalizing cancer therapy. Within liquid biopsy, the detection and molecular characterization of circulating tumor cells (CTCs) – the ‘needle in the haystack’ circulating epithelial cells originating from tumors – is an active area of research.
Over the past three months, we carried out a Spotlight on circulating tumor cells on Oncology Central, highlighting key journal content discussing the topic, featuring exclusive content from experts in the field and finding out more on your thoughts on the current applications of CTCs and their future adoption in the clinic in our survey.
Below you can find information on all the content associated with this Spotlight – we’ll be adding to it frequently, so be sure to keep checking back.
Thanks to all those who took the time to respond to our CTCs survey – the results have now been published on Oncology Central in our stunning infographic. Click here to gain a visual snapshot of what our respondents believe is the current status of this field and the perceived road ahead.